- Report
- February 2025
- 100 Pages
Global
From €5347EUR$5,950USD£4,535GBP
- Report
- April 2025
- 175 Pages
Global
From €4035EUR$4,490USD£3,422GBP
- Report
- April 2025
- 175 Pages
Global
From €4035EUR$4,490USD£3,422GBP
- Report
- April 2025
- 175 Pages
Global
From €4035EUR$4,490USD£3,422GBP
- Report
- April 2025
- 175 Pages
Global
From €4035EUR$4,490USD£3,422GBP
- Report
- April 2025
- 200 Pages
Global
From €4035EUR$4,490USD£3,422GBP
- Report
- June 2024
- 76 Pages
Global
From €1258EUR$1,400USD£1,067GBP
- Report
- March 2022
- 55 Pages
Global
From €1797EUR$2,000USD£1,524GBP
€3595EUR$4,000USD£3,049GBP
- Report
- May 2024
- 180 Pages
Global
From €3438EUR$3,825USD£2,915GBP
€4044EUR$4,500USD£3,430GBP
- Report
- March 2022
- 98 Pages
Global
From €3500EUR$4,172USD£3,072GBP
- Report
- March 2024
- 84 Pages
Global
From €3500EUR$4,172USD£3,072GBP
- Book
- February 2024
- 800 Pages
- Book
- January 2024
- 800 Pages

Plasma Medicine is a field of healthcare services that focuses on the use of plasma-based therapies to treat a variety of medical conditions. Plasma is the liquid component of blood, and it contains proteins, antibodies, and other molecules that can be used to treat a variety of diseases. Plasma-based therapies are used to treat conditions such as cancer, autoimmune diseases, and genetic disorders. Plasma-based therapies can also be used to treat infections, wounds, and burns.
Plasma Medicine is a rapidly growing field of healthcare services, with new treatments and technologies being developed to improve patient outcomes. Plasma-based therapies are often used in combination with other treatments, such as chemotherapy and radiation therapy, to provide a more comprehensive approach to patient care.
Some companies in the Plasma Medicine market include Grifols, CSL Behring, Octapharma, Kedrion, and Biotest. Show Less Read more